Managing Partner
Soon Woong Kim
Patent Attorney / Founder / Managing Partner
- +82-2-6677-7602
- swkimip@jjpat.com
Practice Areas
Bio/Chemistry
Education and
Qualifications
- Completed Ph.D. coursework in Dental Regenerative Biology, Seoul National University
- M.S. in Theriogenology and Biotechnology, College of Veterinary Medicine, Seoul National University
- B.S. in Veterinary Medicine, Seoul National University
- Passed the 37th Patent Attorney Examination (2000)
- Doctor of Veterinary Medicine (D.V.M.) (2003)
- Certified Technology Transfer Professional (2006)
Career
Current)
- Managing Partner, JUNGJIN Patent & Law Firm
- Managing Partner, JUNGJIN Intellectual Property Strategy Institute
- Adjunct Professor, Department of Biotechnology, Inha University
Previous)
- Director of Technology Transfer, Seoul National University Research & Business Foundation
- Adjunct Professor, Graduate School, Gyeongsang National University
- CEO, Altero Biotech Co., Ltd.
- Patent Attorney, Bukchon Law Office
- Patent Attorney, Hanol Patent & Law Office
Bailiwick
Biotechnology / Chemistry / Veterinary Medicine / Dental Regenerative Biology / Stem Cells / Patent Filing and Technology Commercialization
Main activity
- Awarded Commendation for Contributions to the Advancement of the Intellectual Property Service Industry (Chairman of the Presidential Council on Intellectual Property Award) (2025)
- Grand Prize, IP-R&D Division, 19th Korea Promising Patent Technology Awards (2024)
- Reappointed as Technical Advisor, Korea Fair Trade Commission (2023)
- Appointed as Evaluator, Integrated Research Information System (IRIS) (2023)
- Awarded in the IP Services Division, 17th Korea Promising Patent Technology Awards (2022)
- Appointed as Evaluator for the LINC 3.0 Innovation-Type LINK Project Group (2022)
- Incorporated JUNGJIN Patent & Law Firm (2022)
- Appointed as Technical Advisor, Korea Fair Trade Commission (2021)
- Signed MOU between North Chungcheong Provincial Government and K-Bio LabCentral (2021)
- Brokered Technology Transfer Agreement between KRIBB Korea Research Institute of Bioscience and Biotechnology and Ingenium Therapeutics Co., Ltd. for NK Cell Therapy Technology (2021)
- Designated as a Certified Technology Transfer Institution by the Ministry of Trade, Industry and Energy, and as an Industrial Property Rights Diagnosis Institution (Chemistry/Biotechnology fields) by the Korean Intellectual Property Office (2020)
- Selected as a Partner Institution for Seoul BioHub (2020)
- Supported the Startup of SerenLife Co., Ltd. (2019)
- Hosted Tech-Fair and participated in Global C&D Support Project of the Korea Drug Development Fund (2016)
- Appointed as Member of the "Korea Technology Commercialization Advisory Group" by Korea Institute for Advancement of Technology (KIAT) (2015)
- Spun off JUNGJIN Intellectual Property Strategy Institute from JUNGJIN International Patent Law Office (2015)
- Appointed as Expert Member of the "Technology Commercialization Expert Council" by the Research Commercialization and Promotion Center (2014)
- Appointed as Commercialization Expert for the "Utilization and Promotion of Promising Technologies" project by the Ministry of Science, ICT and Future Planning (2014)
- Awarded Technology Commercialization Award by the Research & Development Promotion Foundation (2012)
- Awarded by the Minister of Environment for Policy Research on Responses to the Nagoya Protocol (2011)
- Member of the Venture and Innovation Business Committee, Korean Patent Attorneys Association (2008)
- Member of the Evaluation Committee for New Product Certification (NEP) (2008)
- Appointed as Expert Consultant for Comprehensive Patent Consulting, Gyeongnam Intellectual Property Center (2007)
- Established JUNGJIN International Patent Law Office (2006)
Key achievements
- Technology transfer brokerage of NK cell therapy between KRIBB and Ingenium Therapeutics (2021)
- Planning research and trend analysis on biomarkers for dementia prevention for Company K (2020)
- Consulting on strategy development for technology licensing agreement for Company K (2020)
- Review of patent infringement and construction of patent portfolio for xenotransplantation technology for Company J (2019)
- Consulting on prevention of international intellectual property disputes (Nagoya Protocol) for Company K (2019)
- Patent trend analysis for biosensors for Company P (2018)
- Consulting on prevention of mosquito repellent infringement disputes for Company W (2018)
- Technology valuation of over-the-counter (OTC) pharmaceutical technologies for Company J (2017)
- Patent diagnosis and construction of patent portfolio for protein therapeutics for Company A (2017)
- Lectures and patent seminars at various institutions including KAIST, Chungnam National University, Changwon National University, Gyeongsang National University, Asan Medical Center, and The Catholic University of Korea.